CRINETICS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.5 USD | -2.21% |
|
+0.24% | +39.12% |
| 05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
| 05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -2.21% | +0.24% | +39.12% | +121.97% | +88.07% | 3.99B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CRNX Stock
- Charts Crinetics Pharmaceuticals, Inc.
- Comparison Chart
